Article Text

Download PDFPDF

Endometrial cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes
  1. C. A. Amezcua*,
  2. H. R. Macdonald,
  3. C. A. Lum*,
  4. W. Yi,
  5. L. I. Muderspach,
  6. L. D. Roman and
  7. J. C. Felix*,
  1. * Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, California
  2. Department of Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, California
  3. Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, California
  1. Address correspondence and reprint requests to: Prof. Juan C. Felix, MD, Department of Pathology, University of Southern California Keck School of Medicine, 1240 N. Mission Rd., Rm. 1L23, Los Angeles, CA 90033, USA. Email: felix{at}usc.edu

Abstract

In this study, we examine the prevalence of finding isolated tumor cells (ITCs) in negative lymph nodes of endometrial cancer patients using immunohistochemistry. Seventy-six endometrial cancer patients with lymph nodes histologically negative for metastatic disease were examined. Nodal tissue sections were stained with anticytokeratin antibodies AE-1 and CAM 5.2. Nodes with single or groups of cells (two to four cells) ≤0.2 mm and showing cytokeratin reactivity were positive for ITCs. Findings were compared to features of the primary tumor and patient outcome. ITCs were present in 31 of 1712 lymph nodes. Fifteen (19.7%) patients had ITC-positive nodes. ITCs involved only pelvic nodes in nine cases, only para-aortic nodes in five cases, and pelvic and para-aortic in one case. Tumor in adnexa was the only pathologic feature associated with nodal ITCs (P = 0.0485). All 15 patients with nodal ITCs were alive at follow-up. One (6.7%) patient suffered recurrent disease but was alive at last encounter. Disease recurred in 5 (8.8%) of 57 patients without nodal ITCs. Two are alive without disease, two alive with disease, and one died from her cancer. In summary, a significant proportion of endometrial cancer patients have ITCs detected by immunohistochemistry in histologically negative regional lymph nodes.

  • cytokeratin
  • endometrial adenocarcinoma
  • immunohistochemistry
  • isolated tumor cells

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.